Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt (Q89500648)
Jump to navigation
Jump to search
scientific article published on 24 February 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt |
scientific article published on 24 February 2020 |
Statements
Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt (English)
Yousery Nada
João Carapinha
Ahmad O Noor
Diena M Almasri
Mostafa Al Zaidy
Ahmed Foad